Edit

Senseonics, Incorporated

http://www.senseonics.com/

Last activity: 25.10.2024

Active

Categories: ChemicalDevelopmentExchangeHardwareManagementMedTechProductPublicSensorsTechnology

Senseonics, Inc. is a medical device startup company in Germantown, Maryland, USA (near Washington, DC) developing transformative glucose monitoring products that are intended to enable people with diabetes to confidently live their lives with ease. Utilizing breakthrough fluorescence sensing technology, the Senseonics continuous glucose monitoring ("CGM") system is being designed to be the first fully implantable CGM that is highly accurate and stable throughout its long sensor life.

The system consists of a very small sensor implanted under the skin, an external transmitter, and a mobile medical application, which allows for discreet, easy access to real-time glucose measurements without the need for a dedicated receiver.

Followers

9.66K

Website visits

12K /mo.

Mentions

Location: United States, Maryland, Germantown

Employees: 51-200

Phone: +1 844-736-7348

Total raised: $40M

Founded date: 1996

Facebook

Instagram

Investors 4

Date	Name	Website
-	New Enterp...	nea.com
-	Checkmate ...	checkmatec...
11.03.2021	Abingworth...	abingworth...
-	Delphi Ven...	delphivent...

Funding Rounds 3

Date	Series	Amount	Investors
12.08.2015	-	$10M	-
20.08.2014	-	$10M	-
03.06.2014	-	$20M	-

Mentions in press and media 29

Date	Title	Description
25.10.2024	Senseonics Holdings, Inc. Announces $16 Million Registered Direct Offering	GERMANTOWN, Md., Oct. 25, 2024 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) syst...
02.10.2024	Ascensia Launches World’s First One-Year CGM System, Eversense® 365	What You Should Know: – Ascensia Diabetes Care has announced the U.S. launch of the Eversense® 365 continuous glucose monitoring (CGM) system, an advancement in diabetes management. – Developed by Senseonics Holdings, Inc., Eversense 365 is...
10.09.2024	Cognition Corporation Launches Compass MED: A Revolutionary Solution to Simplify and Accelerate Medical Device Development	As medical devices become increasingly more complex, the need to enhance development efficiency, quality by design, integrated risk management, and regulatory compliance has never been greater LEXINGTON, Mass., Sept. 10, 2024 /PRNewswire/ -...
26.06.2023	Data supports safety and accuracy of Senseonics 365-day CGM	The Eversense E3 system. [Image from Ascensia/Senseonics]Senseonics (NYSE: SENS) today announced positive clinical data highlighting the effectiveness of its Eversense continuous glucose monitor (CGM). Germantown, Maryland–based Senseonics ...
10.11.2021	SENSEONICS HOLDINGS, INC. REPORTS THIRD QUARTER 2021 FINANCIAL RESULTS - Form 8-K	SENSEONICS HOLDINGS, INC. REPORTS THIRD QUARTER 2021 FINANCIAL RESULTS GERMANTOWN, MD, November 9, 2021 -Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of long-...
12.08.2021	SENSEONICS : REPORTS SECOND QUARTER 2021 FINANCIAL RESULTS (Form 8-K)	SENSEONICS HOLDINGS, INC. REPORTS SECOND QUARTER 2021 FINANCIAL RESULTS GERMANTOWN, MD, August 9, 2021 -Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of long-t...
02.03.2021	Senseonics to Participate in the H.C. Wainwright Global Life Sciences Conference	GERMANTOWN, Md.--(BUSINESS WIRE)--Mar 2, 2021-- Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of long-term, implantable continuous glucose monitoring (CGM) sys...
28.01.2021	Senseonics Holdings Announces Closing of $115.0 Million Bought Deal Offering of Common Stock and Full Exercise of the Option to Purchase Additional Shares	GERMANTOWN, Md.–(BUSINESS WIRE)–Jan 28, 2021– Senseonics Holdings, Inc. (NYSE American: SENS) (“Senseonics” or the “Company”), a medical technology company focused on the development and commercialization of a long-term, implantable continu...
07.01.2019	Dexcom, glowing from fabulous results, dismisses Medtronic as a viable CGM competitor at JPM	Dexcom CEO Kevin Sayer was positively beaming as he stood in front of a large audience gathered to hear his presentation at the annual J.P. Morgan Healthcare Conference in San Francisco on Monday. Fresh off of pre-announcing fourth quarter ...
17.09.2018	Here’s a look at Maryland’s publicly-traded biotech companies	When talk turns to Maryland’s biotech bonafides, the ideas and talent being produced by government institutions like NIH, and research-oriented universities with connected health systems such as Johns Hopkins and University of Maryland are ...
01.11.2017	As FDA wait continues, Senseonics starts consumer push in early European markets	Implantable continuous glucose monitor (CGM) maker Senseonics is still making the long trudge toward FDA clearance, but at least the company has plenty of European activity to keep it occupied in the meantime. On a Q3 earnings call, CEO Tim...
30.07.2016	Apple's Patent-Pending Invention Highlights Advancing work on a Tele-Medicine Sessions System Categories Search	Earlier this month the U.S. Patent and Trademark Office published a patent application from Apple revealing an invention that could one day play a part in Apple's Health Platform through HealthKit. Today Apple's Health app gives users an ea...
14.01.2016	Pre-FDA, smartphone-connected, implantable CGM company Senseonics files for $51.75M IPO	Senseonics, a Germantown, Maryland-based company working on a longterm implantable continuous glucose monitor, has filed to go public with an IPO that, for now at least, is valued at $51.75 million. Senseonics singular offering is a pill-si...
12.08.2015	Senseonics raises $10M for implanted, smartphone-connected glucose sensor	Germantown, Maryland-based continuous glucose monitor device maker Senseonics raised $10 million, according to an SEC filing. The company has not yet responded to a request for comment. Existing investors include Anthem Capital, Delphi Vent...
06.01.2015	Implantable continuous glucose monitor moves closer to market with $12M Series C	Continuous glucose monitors are in hot demand from diabetics: Even the most diligent finger sticking doesn’t give patients a complete picture of how their blood sugar peaks and valleys. But current models of CGMs involve an externally-worn ...
27.10.2014	Now there’s a periodic table for the Internet of Things	Remote monitoring Alongside the companies receiving investment and making investments, it could include the companies that are supporting the monitoring — the kind with wall to wall screens and everyone has a headset. The hybrids The conver...
20.08.2014	Senseonics Receives $10M Loan	Senseonics, Inc., a Germantown, MD-based developer of technology for glucose monitoring , received a $10m senior secured term loan. Oxford Finance LLC, a specialty finance firm that provides senior debt to life sciences and healthcare servi...
06.06.2014	Senseonics Raises Additional $20M Equity Financing	Senseonics, a Germantown, MD-based medical device company, raised an additional $20m of equity financing. Backers included Anthem Capital, Delphi Ventures, Greenspring Associates, Healthcare Ventures, New Enterprise Associates and other str...
06.06.2014	Senseonics Raises $20M	GERMANTOWN, MD, Privately held medical device company has raised an additional $20 million of private equity financing. >> Click here for more funding data on Senseonics >> To export Senseonics funding data to PDF and Excel,...
06.06.2014	Senseonics takes $20 million to advance its connected glucometer implant	In the wake of Apple’s bombshell announcement of its HealthKit health information platform, Maryland-based glucometer implant company Senseonics says it’s taken another $20 million in funding. The company makes a small tube-shaped implant t...
06.06.2014	Senseonics nets $20M, starts trials for connected, embedded continuous glucose monitor	Germantown, Maryland-based continuous glucose monitor developer Senseonics raised $20 million from existing investors Anthem Capital, Delphi Ventures, Greenspring Associates, Healthcare Ventures, and New Enterprise Associates. This brings t...
05.06.2014	Diabetes: Senseonics raises $20M for continuous glucose monitoring implant	UPDATED June 5, 2014, with new round total and comment from Senseonics. Senseonics said it raised $20 million it plans to put toward pivotal trials of its fully implantable blood glucose monitor for Type I and Type II diabetics, tapping a f...
03.06.2014	Senseonics raised $20 million to advance continuous glucose monitoring implant	Pivotal trials have begun in Amsterdam and are scheduled for this summer in Germany and the UK and take about one year. After it secures a greenlight for its IDE application, Senseonics expects to begin clinical trials in the U.S. next year...
25.09.2013	Sagentia partners with Senseonics to develop novel connected health solution for diabetics	Sagentia partners with Senseonics to develop novel connected health solution for diabetics 25-09-2013 Sagentia, a global technology and product development company, announced that it has developed a medically regulated iPhone app for the Se...
-	Senseonics raised $20 million to advance continuous glucose monitoring implant	There are just a handful of big medical device companies that dominate the continuous glucose monitoring space and Senseonics is looking to compete with them. It has raised $20 million across two tranches from current investors to advance a...
-	Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2020 Financial Results	GERMANTOWN, Md.--(BUSINESS WIRE)--Mar 4, 2021-- Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of long-term, implantable continuous glucose monitoring (CGM) sys...
-	Implantable continuous glucose monitor moves closer to market with $12M Series C	San Diego startup GlySens says its implantable continuous glucose monitor is in the homestretch: It has a few more developmental tweaks to finish on its diabetes-tracking device, and just closed a $12 million Series C that’ll help get it ma...
-	Dexcom, glowing from fabulous results, dismisses Medtronic as a viable CGM competitor at JPM	Dexcom CEO Kevin Sayer was positively beaming as he stood in front of a large audience gathered to hear his presentation at the annual J.P. Morgan Healthcare Conference in San Francisco on Monday. Fresh off of pre-announcing fourth quarter ...
-	Now there’s a periodic table for the Internet of Things	After the attention CB Insights got for its periodic tables for technology and healthcare, it has taken on the Internet of Things category and condenses the technology subsector into the most vital parts. It includes eight healthcare compan...

Senseonics, Incorporated

Investors 4

Funding Rounds 3

Mentions in press and media 29

Reviews 0